Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Insights/Future of CT in congenital heart disease

Future of CT in congenital heart disease

Lower dose, more automation, and imaging that feeds directly into planning rather than only into reports.

Cardiac imaging

Dose reduction as the continuing direction

Photon-counting CT and advanced reconstruction continue the trajectory toward diagnostic imaging at progressively lower dose. The direction of travel is clear even where specific figures are not yet established in congenital populations, where patient numbers are small and anatomy heterogeneous.

Automation

Automated segmentation of complex congenital anatomy is the step that would make three-dimensional modelling routine rather than a research activity. Manual segmentation is the bottleneck, and congenital anatomy is precisely the case where generic tools perform worst because the anatomy departs from the normal template the model learned.

That makes it a demanding test of automated methods, and validation in congenital cohorts specifically — not extrapolated from adult acquired disease — is essential.

From image to intervention

Patient-specific modelling for surgical and catheter planning, including printed models and computational flow simulation. The research question is whether planning changes decisions and improves outcomes, which requires clinical evaluation rather than demonstration of technical feasibility.

Lifetime imaging strategy

As more patients survive into adulthood, the question becomes how to image them over decades: which modality when, how often, and how to hold a cumulative dose record across institutions. This is a health-services question as much as a technical one, and is poorly served by current systems.

Methodological needs

Multicentre collaboration, because single centres see too few of any specific lesion. Registries with standardised imaging data. Outcome-based evaluation rather than image-quality endpoints alone.

In short

What to take from this.

  • Validate automated segmentation in congenital cohorts, not by extrapolation.
  • Technical feasibility is not clinical utility — evaluate decisions and outcomes.
  • Cumulative cross-institutional dose tracking remains unsolved.

Sources

  • Paediatric and congenital cardiac imaging literature
  • Literature on patient-specific modelling and surgical planning

This page reflects established understanding as at mid-2026 and is not a current-awareness service. Clinical and regulatory positions change; verify anything decision-relevant against a current source.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.